Seeking Alpha

SVON
  Sevion Therapeutics, Inc. - OTCQB

11/23/2014, 8:13 PM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
SVON vs. ETF Alternatives
Company Description
The primary business of the Company is to utilize our patented and patent-pending technology related to antibody genes, antibody discovery technology, modified cow antibodies, and antibody drug candidates, and certain genes, primarily eukaryotic translation initiation Factor 5A, or Factor 5A,... More
Sector: Healthcare
Industry: Biotechnology
Country: United States